These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8508358)

  • 1. Proliferation index as a prognostic marker in breast cancer.
    Veronese SM; Gambacorta M; Gottardi O; Scanzi F; Ferrari M; Lampertico P
    Cancer; 1993 Jun; 71(12):3926-31. PubMed ID: 8508358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
    Veronese SM; Maisano C; Scibilia J
    Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences.
    Gaglia P; Bernardi A; Venesio T; Caldarola B; Lauro D; Cappa AP; Calderini P; Liscia DS
    Eur J Cancer; 1993; 29A(11):1509-13. PubMed ID: 8217353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic significance of the S-phase and MIB1 (Ki-67) proliferation parameters in node-negative breast carcinoma].
    Harbeck N; Dettmar P; Thomssen Ch; Pache L; Ziffer P; Fizi K; Jänicke F; Nathrath W; Schmitt M; Graeff H
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():142-7. PubMed ID: 8672914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.
    Bevilacqua P; Verderio P; Barbareschi M; Bonoldi E; Boracchi P; Dalla Palma P; Gasparini G
    Breast Cancer Res Treat; 1996; 37(2):123-33. PubMed ID: 8750580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival.
    Magno WB; Hirschfield L; Bhuiya T; Harrison G; Mir R
    Conn Med; 1992 Dec; 56(12):667-9. PubMed ID: 1363223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the proliferation rate on the course of node negative breast carcinoma].
    Mitze M; Weikel W; Brumm C; Lippold R; Knapstein PG
    Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):299-305. PubMed ID: 7657137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer.
    Campani D; Sarnelli R; Fontanini G; Martini L; Cecchetti D; De Luca F; Squartini F
    Ann N Y Acad Sci; 1993 Nov; 698():167-73. PubMed ID: 7904137
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
    Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
    Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between pS2 protein positivity, steroid receptor status and other prognostic factors in breast cancer.
    Racca S; Conti G; Pietribiasi F; Stramignoni D; Tampellini M; Valetto MR; Ghezzo F; Di Carlo F
    Int J Biol Markers; 1995; 10(2):87-93. PubMed ID: 7561244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast carcinoma: evaluation of hormone receptors and pS2, erb-B2, P-glycoprotein and Ki-67 markers].
    Abadjian G; Antoun R
    J Med Liban; 1996; 44(1):10-5. PubMed ID: 8965315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunohistochemical growth fraction (Ki-67) of breast cancers: relations to tumor spread, tumor morphology and receptor testing].
    Weikel W; Beck T; Rosenthal H; Herzog R
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):277-82. PubMed ID: 2566552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.
    Rudolph P; Alm P; Heidebrecht HJ; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R
    J Natl Cancer Inst; 1999 Feb; 91(3):271-8. PubMed ID: 10037106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis.
    Rudas M; Gnant MF; Mittlböck M; Neumayer R; Kummer A; Jakesz R; Reiner G; Reiner A
    Breast Cancer Res Treat; 1994; 32(2):165-75. PubMed ID: 7865846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features.
    Veronese SM; Gambacorta M
    Am J Clin Pathol; 1991 Jan; 95(1):30-4. PubMed ID: 1987749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer. Relationship between differentiation degree and axillary lymph node metastases.
    Sirvent JJ; Santafé M; Salvadó MT; Alvaro T; Raventós A; Palacios J
    Histol Histopathol; 1994 Jul; 9(3):563-70. PubMed ID: 7526910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
    Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
    J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.
    Sahin AA; Ro J; Ro JY; Blick MB; el-Naggar AK; Ordonez NG; Fritsche HA; Smith TL; Hortobagyi GN; Ayala AG
    Cancer; 1991 Aug; 68(3):549-57. PubMed ID: 1648433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B; Bethwaite PB; Thornton A; Ribas JL
    Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear markers (star volume, mitotic index, AgNOR and Ki-67) of the primary tumor and its metastasis in non-small cell lung carcinomas.
    Matheus RS; Bernardi Fdel C; Gallo CP; da Silva AP; Rodrigues OR; Capelozzi M; Lopes A; Fenezelian S; Saldiva PH; Capelozzi VL
    Pathol Res Pract; 2004; 200(1):13-23. PubMed ID: 15157046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.